HT, M., BA, D., H, M., & SK, K. (2025). Changing lanes: Extending CAR T-cell therapy to high-risk plasma cell dyscrasias. Frontiers in immunology, 16, 1558275. https://doi.org/10.3389/fimmu.2025.1558275
Chicago Style (17th ed.) CitationHT, Morgan, Derman BA, Ma H, and Kumar SK. "Changing Lanes: Extending CAR T-cell Therapy to High-risk Plasma Cell Dyscrasias." Frontiers in Immunology 16 (2025): 1558275. https://doi.org/10.3389/fimmu.2025.1558275.
MLA (9th ed.) CitationHT, Morgan, et al. "Changing Lanes: Extending CAR T-cell Therapy to High-risk Plasma Cell Dyscrasias." Frontiers in Immunology, vol. 16, 2025, p. 1558275, https://doi.org/10.3389/fimmu.2025.1558275.
Warning: These citations may not always be 100% accurate.